$88.26
0.060.07%
At Close: -
$88.25
-0.01-0.01%
After Hours: Jul 19, 4:03 PM EDT
15 minutes delayed
Comments
Loading...
Globe Life
GLNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Globe Life (NYSE:GL) Stock, Analyst Ratings, Price Targets, Forecasts
Globe Life Inc has a consensus price target of $104.38 based on the ratings of 14 analysts. The high is $140 issued by Credit Suisse on December 19, 2022. The low is $65 issued by Morgan Stanley on July 10, 2024. The 3 most-recent analyst ratings were released by Morgan Stanley, Jefferies, and Piper Sandler on July 10, 2024, June 28, 2024, and June 28, 2024, respectively. With an average price target of $86 between Morgan Stanley, Jefferies, and Piper Sandler, there's an implied -2.55% downside for Globe Life Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Jefferies
Piper Sandler
Evercore ISI Group
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Globe Life
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/10/2024 | Buy Now | -26.35% | Morgan Stanley | Nigel Dally | $62 → $65 | Maintains | Equal-Weight | Get Alert |
| 06/28/2024 | Buy Now | -0.28% | Jefferies | Suneet Kamath | $85 → $88 | Maintains | Hold | Get Alert |
| 06/28/2024 | Buy Now | 18.98% | Piper Sandler | John Barnidge | $110 → $105 | Maintains | Overweight | Get Alert |
| 06/26/2024 | Buy Now | -2.55% | Evercore ISI Group | Thomas Gallagher | $83 → $86 | Maintains | In-Line | Get Alert |
| 05/21/2024 | Buy Now | — | Raymond James | Wilma Burdis | — | Reiterates | → Strong Buy | Get Alert |
| 04/24/2024 | Buy Now | 22.38% | Wells Fargo | Elyse Greenspan | $132 → $108 | Maintains | Overweight | Get Alert |
| 04/24/2024 | Buy Now | 24.65% | Keefe, Bruyette & Woods | Ryan Krueger | $130 → $110 | Upgrade | Market Perform → Outperform | Get Alert |
| 04/24/2024 | Buy Now | 24.65% | Piper Sandler | John Barnidge | $130 → $110 | Maintains | Overweight | Get Alert |
| 04/24/2024 | Buy Now | -9.35% | Truist Securities | Mark Hughes | $125 → $80 | Maintains | Hold | Get Alert |
| 04/12/2024 | Buy Now | 41.64% | Truist Securities | Mark Hughes | $125 → $125 | Maintains | Hold | Get Alert |
| 04/12/2024 | Buy Now | -15.01% | Evercore ISI Group | Thomas Gallagher | $125 → $75 | Maintains | In-Line | Get Alert |
| 04/11/2024 | Buy Now | 49.58% | Wells Fargo | Elyse Greenspan | $146 → $132 | Maintains | Overweight | Get Alert |
| 04/10/2024 | Buy Now | 47.31% | Keefe, Bruyette & Woods | Ryan Krueger | $135 → $130 | Maintains | Market Perform | Get Alert |
| 04/05/2024 | Buy Now | 47.31% | Piper Sandler | John Barnidge | $143 → $130 | Maintains | Overweight | Get Alert |
| 03/14/2024 | Buy Now | 41.64% | Evercore ISI Group | Thomas Gallagher | $138 → $125 | Maintains | In-Line | Get Alert |
| 02/09/2024 | Buy Now | 41.64% | Truist Securities | Mark Hughes | $115 → $125 | Maintains | Hold | Get Alert |
| 02/08/2024 | Buy Now | 54.11% | JP Morgan | Jimmy Bhullar | $133 → $136 | Maintains | Overweight | Get Alert |
| 11/15/2023 | Buy Now | 49.58% | Morgan Stanley | Nigel Dally | $131 → $132 | Maintains | Equal-Weight | Get Alert |
| 10/31/2023 | Buy Now | 55.24% | Wells Fargo | Wesley Carmichael | $122 → $137 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/23/2023 | Buy Now | 81.3% | Raymond James | Wilma Burdis | $138 → $160 | Maintains | Strong Buy | Get Alert |
| 10/06/2023 | Buy Now | 49.58% | JP Morgan | Jimmy Bhullar | $131 → $132 | Maintains | Overweight | Get Alert |
| 09/14/2023 | Buy Now | 33.71% | Jefferies | Suneet Kamath | $115 → $118 | Maintains | Hold | Get Alert |
| 08/18/2023 | Buy Now | 48.44% | Morgan Stanley | Nigel Dally | → $131 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 08/02/2023 | Buy Now | 48.44% | Morgan Stanley | Nigel Dally | $131 → $131 | Reiterates | Underweight → Underweight | Get Alert |
| 07/27/2023 | Buy Now | 48.44% | Morgan Stanley | Nigel Dally | $130 → $131 | Maintains | Underweight | Get Alert |
| 07/17/2023 | Buy Now | 38.24% | Wells Fargo | Elyse Greenspan | $121 → $122 | Maintains | Equal-Weight | Get Alert |
| 06/09/2023 | Buy Now | 43.91% | Keefe, Bruyette & Woods | Ryan Krueger | → $127 | Reiterates | → Market Perform | Get Alert |
| 05/15/2023 | Buy Now | 37.11% | Wells Fargo | Elyse Greenspan | $120 → $121 | Maintains | Equal-Weight | Get Alert |
| 05/05/2023 | Buy Now | 30.31% | Truist Securities | Mark Hughes | $125 → $115 | Maintains | Hold | Get Alert |
| 05/05/2023 | Buy Now | 47.31% | Piper Sandler | John Barnidge | $135 → $130 | Maintains | Overweight | Get Alert |
| 05/04/2023 | Buy Now | 47.31% | Morgan Stanley | Nigel Dally | $129 → $130 | Maintains | Underweight | Get Alert |
| 04/25/2023 | Buy Now | 35.98% | Wells Fargo | Elyse Greenspan | → $120 | Initiates | → Equal-Weight | Get Alert |
| 04/12/2023 | Buy Now | 46.18% | Morgan Stanley | Nigel Dally | $133 → $129 | Maintains | Underweight | Get Alert |
| 03/14/2023 | Buy Now | 56.37% | Raymond James | Wilma Burdis | $141 → $138 | Maintains | Strong Buy | Get Alert |
| 02/24/2023 | Buy Now | 50.71% | Morgan Stanley | Nigel Dally | $132 → $133 | Maintains | Underweight | Get Alert |
| 02/15/2023 | Buy Now | 59.77% | Raymond James | Wilma Burdis | $138 → $141 | Maintains | Strong Buy | Get Alert |
| 02/03/2023 | Buy Now | 41.64% | Truist Securities | Mark Hughes | $112 → $125 | Maintains | Hold | Get Alert |
| 01/10/2023 | Buy Now | 49.58% | Morgan Stanley | Nigel Dally | $115 → $132 | Maintains | Underweight | Get Alert |
| 01/06/2023 | Buy Now | 42.78% | JP Morgan | Jimmy Bhullar | $112 → $126 | Maintains | Overweight | Get Alert |
| 12/20/2022 | Buy Now | 47.31% | Piper Sandler | John Barnidge | $127 → $130 | Maintains | Overweight | Get Alert |
| 12/19/2022 | Buy Now | 58.64% | Credit Suisse | Andrew Kligerman | $130 → $140 | Maintains | Outperform | Get Alert |
| 11/17/2022 | Buy Now | 30.31% | Morgan Stanley | Nigel Dally | $112 → $115 | Maintains | Underweight | Get Alert |
| 10/28/2022 | Buy Now | 26.91% | Truist Securities | Mark Hughes | $100 → $112 | Maintains | Hold | Get Alert |
| 10/28/2022 | Buy Now | 29.18% | Evercore ISI Group | Russell Haug | $115 → $114 | Downgrade | Outperform → In-Line | Get Alert |
| 10/27/2022 | Buy Now | 26.91% | Morgan Stanley | Nigel Dally | $110 → $112 | Maintains | Underweight | Get Alert |
| 09/22/2022 | Buy Now | 56.37% | Raymond James | Wilma Burdis | → $138 | Initiates | → Strong Buy | Get Alert |
| 08/17/2022 | Buy Now | 24.65% | Morgan Stanley | Nigel Dally | $109 → $110 | Maintains | Underweight | Get Alert |
| 07/28/2022 | Buy Now | 23.51% | Morgan Stanley | Nigel Dally | $107 → $109 | Maintains | Underweight | Get Alert |
| 07/11/2022 | Buy Now | 26.91% | JP Morgan | Jimmy Bhullar | $108 → $112 | Maintains | Overweight | Get Alert |
| 07/08/2022 | Buy Now | 37.11% | Piper Sandler | John Barnidge | $119 → $121 | Maintains | Overweight | Get Alert |
| 06/15/2022 | Buy Now | 26.91% | Evercore ISI Group | Russell Haug | $105 → $112 | Upgrade | In-Line → Outperform | Get Alert |
| 02/22/2022 | Buy Now | 21.25% | Morgan Stanley | Nigel Dally | $105 → $107 | Maintains | Underweight | Get Alert |
| 01/26/2022 | Buy Now | 20.11% | Jefferies | Suneet Kamath | → $106 | Initiates | → Hold | Get Alert |
| 01/21/2022 | Buy Now | -3.68% | Wolfe Research | Michael Zaremski | → $85 | Initiates | → Underperform | Get Alert |
| 01/12/2022 | Buy Now | 32.58% | Piper Sandler | John Barnidge | $105 → $117 | Upgrade | Neutral → Overweight | Get Alert |
| 01/07/2022 | Buy Now | 18.98% | Morgan Stanley | Nigel Dally | $103 → $105 | Maintains | Underweight | Get Alert |
| 11/18/2021 | Buy Now | 16.71% | Morgan Stanley | — | — | Maintains | Underweight | Get Alert |
| 10/19/2021 | Buy Now | 47.31% | Credit Suisse | Andrew Kligerman | — | Maintains | Outperform | Get Alert |
| 07/22/2021 | Buy Now | 25.78% | JP Morgan | Jimmy Bhullar | $110 → $111 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Globe Life (GL) stock?
The latest price target for Globe Life (NYSE:GL) was reported by Morgan Stanley on July 10, 2024. The analyst firm set a price target for $65.00 expecting GL to fall to within 12 months (a possible -26.35% downside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Globe Life (GL)?
The latest analyst rating for Globe Life (NYSE:GL) was provided by Morgan Stanley, and Globe Life maintained their equal-weight rating.
When was the last upgrade for Globe Life (GL)?
The last upgrade for Globe Life Inc happened on April 24, 2024 when Keefe, Bruyette & Woods raised their price target to $110. Keefe, Bruyette & Woods previously had a market perform for Globe Life Inc.
When was the last downgrade for Globe Life (GL)?
The last downgrade for Globe Life Inc happened on October 28, 2022 when Evercore ISI Group changed their price target from $115 to $114 for Globe Life Inc.
When is the next analyst rating going to be posted or updated for Globe Life (GL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Globe Life, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Globe Life was filed on July 10, 2024 so you should expect the next rating to be made available sometime around July 10, 2025.
Is the Analyst Rating Globe Life (GL) correct?
While ratings are subjective and will change, the latest Globe Life (GL) rating was a maintained with a price target of $62.00 to $65.00. The current price Globe Life (GL) is trading at is $88.25, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.